Auvelity cleared for agitation in Alzheimer's dementia

What this means

Auvelity is a combination pill containing dextromethorphan (a cough suppressant) and bupropion (an antidepressant) that works by affecting brain chemicals linked to mood and agitation. The FDA just approved Auvelity for treating agitation in Alzheimer's dementia patients, based on clinical trial data showing it reduced symptoms better than placebo. This gives caregivers a new medication option for managing the distressing agitation that often accompanies Alzheimer's disease.